Employees work in the manufacturing of Pfizer’s new respiratory syncytial

FILE PHOTO: Employees work in the manufacturing of Pfizer’s new respiratory syncytial virus (RSV) vaccine Abrysvo, in this undated handout picture. Pfizer/Handout via REUTERS/File Photo